ACS selects first project in “accelerator pipeline”

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The American Cancer Society and the Global Center for Medical Innovation selected the first project to be funded under a recently launched partnership to identify, fund, and promote promising medical devices and technologies within the ACS portfolio of current or previously-funded research. The goal of the initiative is to identify and solve critical unmet needs through innovative technology solutions to diagnose and treat cancer and bring them to market.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

People of African ancestry (Black/African American) have some of the worst cancer incidence and greatest mortality, compared to white and other racial and ethnic populations in the U.S. On average, Black persons are 1.5 times more likely to have cancer and >2X more likely to die from cancer compared to whites. xxx:more

Login